In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.
The US Food and Drug Administration (FDA) has proposed an order to ban a popular ingredient in cold and flu medicines as it is seemingly not as effective as other methods. Oral phenylephrine is often ...
Computer literate with knowledge and skills in Record Keeping programs and software. Ability to interpret and understand Fuel records, data and information. Ability to understand Civil Aviation ...
BEIJING, Nov. 11, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the results of the Phase 2b clinical study of GZR18 injection, a bi-weekly ...
It is also an ingredient in nasal sprays to treat congestion. However, the FDA's action is only related to orally administered phenylephrine and not the nasal spray form. Last year, an outside panel ...